ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Water → 1-Methanesulfonyl-3,3-dimethylpiperazine

HRID 1922711
印刷

反応式

HRID 1922711 の反応式
C(OC([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][C:9]1([CH3:15])[CH3:14])=O)(C)(C)C.CCN(CC)CC.[CH3:23][S:24](Cl)(=[O:26])=[O:25].O>C(Cl)Cl>[CH3:14][C:9]1([CH3:15])[NH:8][CH2:13][CH2:12][N:11]([S:24]([CH3:23])(=[O:26])=[O:25])[CH2:10]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 962WaterHCID 8471TriethylamineHCID 31297Methanesulfonyl chlorideHCID 299224001,1-Dimethylethyl 2,2-dimethyl-1-piperazinecarboxylate

生成物 1

HCID 198151421-Methanesulfonyl-3,3-dimethylpiperazine

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒2 回

実験手順

A mixture of 2,2-dimethylpiperazine-1-carboxylic acid tert-butyl ester (1.0 g, 4.60 mmol) and NEt3 (1.3 mL, 9.34 mmol) in DCM (11 mL) was cooled to 0° C. before the drop wise addition of a solution of methanesulfonyl chloride (580 mg, 5.00 mmol) in DCM (2 mL). The resulting mixture was warmed to r.t. and allowed to stir for 30 min before H2O was added. The organic phase was dried (phase separator) and concentrated in vacuo. The resulting residue was dissolved in DCM (10 mL) and TFA (2 mL) was added. The resulting mixture was allowed to stir at r.t. for 30 min then concentrated in vacuo. The resulting residue was partitioned between DCM and sat. aq. NaHCO3 and the aqueous phase was loaded onto an Isolute® SCX-2 cartridge which was washed with H2O and MeOH. The product was eluted with 2M NH3/MeOH affording the title compound (800 mg, 90%). LCMS (method A): RT 0.29 min [M+H]+ 193.3

後処理

  1. additionwas added
  2. customThe organic phase was dried (phase separator)
  3. concentrationconcentrated in vacuo
  4. dissolutionThe resulting residue was dissolved in DCM (10 mL)
  5. additionTFA (2 mL) was added
  6. concentrationthen concentrated in vacuo
  7. customThe resulting residue was partitioned between DCM and sat. aq. NaHCO3
  8. washwas washed with H2O and MeOH
  9. washThe product was eluted with 2M NH3/MeOH affording the title compound (800 mg, 90%)
  10. customRT 0.29 min [M+H]+ 193.3

出典と根拠

ORDレコード
ord-8d833fb5cfdb47d18c450304008084ec
出典データセット
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08173650B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート